Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20220718001Completed
Single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Chulalongkorn University. Primary endpoint: Association between 5-HTTLPR and rs25531 polymorphisms and gastrointestinal intolerance to metformin. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20220718001.